{
    "nct_id": "NCT05676450",
    "official_title": "Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas",
    "inclusion_criteria": "1. Male/female patients who are at least 18 years of age on the day of informed consent signing.\n2. Patients must have a histologically documented diffuse large B-cell lymphoma requiring therapy.\n3. Provision of written informed consent for the study.\n4. Pregnant women not included\n5. Cognitively impaired adults are not included.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "None",
    "miscellaneous_criteria": ""
}